Date:                 Tuesday, 19 November 2013 
Time:                 9.00 – 13.00 (registration opens at 8.30) 

Venue:               PwC office, 10th floor 
                            Eurasia Business Centre 
                            75 Zhylyanska Street, Kyiv 

Language:        Russian 

Free of charge, by invitation only 

Dear Sir/Madam, 

We would like to invite you to a PwC Ukraine’s Business Breakfast for Finance Leaders that will be dedicated to recent developments in the taxation of the pharmaceutical sector.

It has become a tradition for us to arrange annual events for pharmaceutical companies to discuss the changes in the Ukrainian tax system. And so we are pleased to again invite you to our seminar devoted to the pharmaceutical industry. We will discuss the most important changes in tax, customs and regulatory areas relevant for pharmaceutical companies. During the event you will have an opportunity to exchange views with your colleagues from other multinational and local pharmaceutical companies, as well as discuss any issues that may be of interest for you with our advisors.

Main topics:

  1. Peculiarities of application of the new transfer pricing by pharmaceutical companies
  2. Effect of introduction Good Promotion Practice on the tax regime of promotion of pharmaceutical products in Ukraine
  3. Permanent establishments in Ukraine: risk of VAT on financing
  4. Trends in the practice of the Antimonopoly Committee of Ukraine: tax risks
  5. Salary in foreign currency ban - options for restructuring
  6. Potential impact of the EU Association Agreement on the Ukrainian pharmaceutical sector
  7. Other matters:

a. peculiarities of payment of Unified Social Contribution according to the clarifications of the Ministry of Revenues and Charges (salary advances, per diems, payments to private entrepreneurs on unified tax and general system, reporting)

b. free distribution/receipt of goods ( VAT and corporate income tax implications from 1 September 2013)

c. fringe benefits to employees (apartment, car , food, mobile): peculiarities of taxation in view of clarifications and changes in legislation

d. the risk of a permanent establishment: the latest practice

e. impact of the possible introduction of VAT on pharmaceuticals on tax accounting

Should you be interested in attending thePwC Pharmaceutical Business Breakfast, please join us on Tuesday, 19 November 2013. If you are unavailable that day, you are welcome to pass this invitation on to another senior representative of your company. We will also be grateful if you share this invitation with your colleagues in the industry from other companies. 

Please confirm your attendance with Myroslava Suprunyuk by email: myroslava.suprunyuk@ua.pwc.com by Friday, 15 November 2013. 

Yours sincerely, 

Ron Barden                                          Svetlana Bilyk                               Oleg Shmal                         
Senior Partner                                             Director                                Senior Manager 
Tax and Legal Services